#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Meningitis meningococcal Exudative retinopathy Factor VIII deficiency Acute promyelocytic leukaemia Acute hepatic failure Propionic acidaemia Congenital nephrogenic diabetes insipidus Acute graft versus host disease in intestine Epilepsy Chronic hepatitis B Rheumatoid arthritis Transitional cell cancer of the renal pelvis and ureter Inflammatory myofibroblastic tumour Aspergillus infection Mucous membrane pemphigoid More trials…

    Learn about Rare Diseases

    Alport’s syndrome – Treatment Burkitt’s lymphoma Optic glioma – Basic Information Paroxysmal nocturnal haemoglobinuria – Basic Information Lymphangiosarcoma MELAS syndrome – Trials in Disease Hereditary hypophosphataemic rickets – Basic Information Alveolar rhabdomyosarcoma – Basic Information Adrenocortical carcinoma – Trials in Disease Gaucher’s disease type I – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rezpegaldesleukin GSKVX000000044501 Citalopram Hydrobromide Ubamatamab Aceclofenac Leflunomide Nebivolol Abiraterone Acetate Dextromethorphan Hydrobromide LINAPRAZAN GLURATE Ribociclib Vb10.16 Frexalimab Sodium Hydrogen Carbonate Suxamethonium Chloride Volixibat Ag-946 Phosphate Azd5004 Isis 678354 Sodium Salt Ly3541860 More therapies…

    Learn about Your Condition

    Type 2 diabetes mellitus Renal cancer metastatic Bile duct cancer Pharyngeal cancer stage II Burning mouth syndrome Actinic cheilitis Infection Ear discomfort Renal cell carcinoma stage IV External cephalic version Breast cancer in situ Lupus nephritis Hypertrophic scar Lower limb fracture Cryoglobulinaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study on the Effectiveness of Bevacizumab and Drug Combination for Children with Recurrent or Progressive Medulloblastoma, Ependymoma, and ATRT

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Medulloblastoma
    Investigated Drugs:
    • Fenofibrate
    • Thalidomide
    • Celecoxib
    Austria Czechia Denmark France Norway Spain +1

  • Study on Treating Status Epilepticus in Seniors Using Levetiracetam and Valproate Semisodium

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Status epilepticus
    Investigated Drugs:
    • Valproate Semisodium
    • Levetiracetam
    Germany

  • Study on the Safety and Effectiveness of Dazucorilant for Patients with Amyotrophic Lateral Sclerosis (ALS)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • Dazucorilant
    Belgium France Germany Ireland The Netherlands Poland +1

  • Study on the Effects of Lenomorelin in Patients with Acute Ischemic Stroke Undergoing Endovascular Thrombectomy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Lenomorelin
    The Netherlands

  • Study of Propranolol Treatment for Brain Hemangioblastomas in Patients with Von Hippel-Lindau Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Von Hippel-Lindau disease
    Investigated Drugs:
    • Propranolol
    France

  • Study on Semaglutide for Weight Control in Patients with Schizophrenia and High BMI Using Antipsychotics

    Recruiting

    3 1 1
    Investigated Diseases:
    • Metabolic disorder
    Investigated Drugs:
    • Semaglutide
    Norway
Previous Page
1 … 53 54 55 56 57 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!